See analyst estimates and all valuation multiples for Pharma Diagnostics & Analytics
| Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| $10.8B | 26.4x | 80.7x | |
| $8.2B | 6.8x | 19.5x | |
| $1.3B | 6.5x | -19.1x | |
| $1.3B | 4.8x | -8.6x | |
| $896M | 19.4x | n/a | |
| $191M | 10.6x | 13.9x | |
| $181M | n/a | n/a | |
| $155M | 6.8x | -5.0x | |
| $38.4M | 2.2x | 11.8x | |
| $29.9M | 12.4x | -7.5x | |
| $19.0M | n/a | -7.9x | |
| $10.6M | n/a | n/a | |
| -$17.1M | -0.6x | n/a | |
| -$21.2M | n/a | 0.3x |
Valuation multiples as of last 12 months (LTM). Financial data powered by Morningstar, Inc.
See analyst estimates and M&A multiples for Pharma Diagnostics & Analytics